Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | MLKL | Q8NB16 | 2/20 | 0.51 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6753938 | 0.90 | ALDH1A1 (0.60) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL29405275 | 0.89 | ALDH1A1 (0.55) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL2679996 | 0.89 | ALDH1A1 (0.55) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL9229885 | 0.88 | ALDH1A1 (0.54) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL18536462 | 0.88 | TAAR1 (0.55) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL28407878 | 0.88 | ALDH1A1 (0.54) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL3467183 | 0.88 | ALDH1A1 (0.54) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL10696885 | 0.88 | ALDH1A1 (0.54) | TAAR1ALDH1A1POLBIDO1MLKL | |
| SCHEMBL17351649 | 0.88 | ALDH1A1 (0.54) | TAAR1ALDH1A1POLBIDO1MLKL | |
| Bromide SCHEMBL1683757 | 0.86 | ALDH1A1 (0.53) | TAAR1ALDH1A1POLBIDO1MLKL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114752362-A | Nano-fluid type wide-temperature-zone heat conduction oil based on ionic liquid and preparation method | 四川大学 | 2022-07-15 | — | — | CN | claimed |
| CN-114437672-A | Ultra-high temperature heat conduction oil based on non-proton type ionic liquid and preparation method thereof | 四川大学 | 2022-05-06 | — | — | CN | claimed |
| CN-1891393-A | Preflux composition | BAIK YANG CHEMICAL CO LTD (KR) | 2007-01-10 | — | — | CN | claimed |
| US-12459060-B2 | Solder paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4056311-B1 | SOLDER PASTE | SENJU METAL INDUSTRY CO (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4015138-B1 | FLUX AND SOLDER PASTE | SENJU METAL INDUSTRY CO (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-11904416-B2 | Solder alloy, solder powder, solder paste and solder joint | SENJU METAL INDUSTRY CO., LTD. (JP) | 2024-02-20 | — | — | US | disclosed |
| CN-113717542-B | Indigo dye vat liquid and preparation method and production device thereof | 广东前进牛仔布有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20230144197-A1 | 4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE | Carrick Therapeutics Limited (IE) | 2023-05-11 | — | — | US | disclosed |
| CN-115433929-A | Organic weldable copper surface protective agent and preparation method thereof | 深圳市豪龙新材料技术有限公司 | 2022-12-06 | — | — | CN | disclosed |
| US-20220331916-A1 | SOLDER PASTE | SENJU METAL INDUSTRY CO., LTD. (JP) | 2022-10-20 | — | — | US | disclosed |
| EP-3188577-A1 | METHOD FOR FORMING ORGANIC COATING ON COPPER SURFACE | Rohm and Haas Electronic Materials LLC (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20170183783-A1 | METHOD FOR FORMING ORGANIC COATING ON COPPER SURFACE | ROHM & HAAS ELECT MAT (US) | 2017-06-29 | — | — | US | disclosed |
| US-9637450-B2 | Octahydrocyclopentapyrroles, their preparation and use | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-05-02 | — | — | US | disclosed |
| CN-1891393-A | Preflux composition | BAIK YANG CHEMICAL CO LTD (KR) | 2007-01-10 | — | — | CN | disclosed |
| US-6712262-B2 | BENZIMIDAZOLE AND IODINE COMPOUNDS | TAMURAKAKEN CORPORATION (JP) | 2004-03-30 | — | — | US | disclosed |
| US-20030203624-A1 | Manufacturing method of semiconductor device | RENESAS TECHNOLOGY CORPORATION (JP) | 2003-10-30 | — | — | US | disclosed |
| CN-1447401-A | Mfg. method of semiconductor device | HITACHI LTD (JP) | 2003-10-08 | — | — | CN | disclosed |
| US-20020067486-A1 | Solderability assessment | AMERICAN COMPETITIVENESS INSTITUTE | 2002-06-06 | — | — | US | disclosed |
| US-5348590-A | Surface treating agent for copper or copper alloys | HITACHI, LTD. (JP) | 1994-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230144197-A1 | 4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE | CDK1, CDK3, CDK2 | TAAR1 4611/4885ALDH1A1 4481/4885POLB 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.